(NP (NP (NN Glucocorticoid) (NNS receptors)) (PP (IN in) (NP (NP (NNS lymphocytes)) (PP (IN in) (NP (NN anorexia) (NN nervosa))))) (. .))
(NP (NP (NP (NN OBJECTIVE) (: :)) (S (NP-SBJ (DT The) (NN aim)) (VP (VBD was) (S-PRD (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN down-regulation)) (PP (IN of) (NP (DT the) (NN glucocorticoid) (NNS receptors))) (PP-TMP (IN during) (NP (NN hypercortisolaemia))) (PP (IN in) (NP (NN anorexia) (NN nervosa)))))))) (. .))))
(NP (NP (NN DESIGN) (: :)) (S-COOD (S (NP-SBJ-31 (NP-COOD (NP (NN Urine)) (CC and) (NP (NN plasma))) (NNS samples)) (VP (VBD were) (VP (VBN obtained) (NP (-NONE- *-31)) (PP (IN for) (NP (NN cortisol) (NN determination)))))) (CC and) (S (NP-SBJ-32 (NN blood) (NNS lymphocytes)) (VP (VBD were) (VP (VBN isolated) (NP (-NONE- *-32)) (PP (IN for) (NP (NN receptor) (NN binding) (NNS studies)))))) (. .)))
(NP (NP (NNS PATIENTS) (: :)) (S (NP-SBJ-COOD-33 (NP (NP (CD Sixteen) (JJ anorexic) (NNS patients)) (, ,) (ADJP (JJ aged) (NP (QP (CD 16-27)) (NNS years))) (, ,) (PP (IN with) (NP (NP (DT a) (NN mean) (CC (- +)) (NN SEM) (NN body) (NN mass) (NN index)) (PP (IN of) (NP (CD 14.2) (CC (- +)) (CD 2.0))) (-LRB- -LRB-) (VP (VBG ranging) (PP-COOD (PP (IN from) (NP (CD 11.1))) (PP (TO to) (NP (CD 17.4))))) (-RRB- -RRB-))) (, ,)) (CC and) (NP (CD 15) (JJ normal) (NNS women))) (VP (VBD were) (VP (VBN studied) (NP (-NONE- *-33)))) (. .)))
(S (NP-SBJ-34 (CD Six) (NNS patients)) (VP (VBD were) (VP (VBN reinvestigated) (NP (-NONE- *-34)) (PP-TMP (IN after) (NP (DT a) (JJ significant) (NN weight) (NN gain))))) (. .))
(NP (NP (NNS MEASUREMENTS) (: :)) (S (NP-SBJ-35 (NP (DT The) (NP (NN binding) (NP-COOD (NP (NN capacity)) (CC and) (NP (NN affinity))))) (PP (IN of) (NP (DT the) (NN glucocorticoid) (NNS receptors)))) (VP (VBD were) (VP (VBN measured) (NP (-NONE- *-35)) (PP (IN with) (NP (NP (NN dexamethasone)) (PP (IN as) (NP (NP (NN ligand)) (PP (IN on) (NP (NNS lymphocytes))))))))) (. .)))
(NP (NP (NNS RESULTS) (: :)) (S (PP (IN In) (NP (NNS patients))) (, ,) (NP-SBJ (ADJP-COOD (DT both) (ADJP (JJ total)) (CC and) (ADJP (JJ free))) (NN plasma) (NN cortisol) (NNS concentrations)) (VP (VBD were) (ADJP-PRD (ADJP (JJR higher)) (PP (IN than) (FRAG (PP (IN in) (NP (DT the) (JJ normal) (NNS women)))))) (, ,) (SBAR (IN as) (SINV (VBD was) (NP-SBJ (PRP$ their) (JJ urinary) (JJ free) (NN cortisol)) (ADJP-PRD (-NONE- *?*))))) (: ;)) (S (NP-SBJ-COOD (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NP (NN glucocorticoid) (NNS receptors)) (PP (IN per) (NP (NN cell)))) (PRN (-LRB- -LRB-) (NP (NN Ro)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (DT the) (NN binding) (NN affinity)) (PRN (-LRB- -LRB-) (NP (NN Kd)) (-RRB- -RRB-))) (PP (IN for) (NP (NN dexamethasone))))) (VP (VBD were) (, ,) (ADVP (RB however)) (, ,) (ADJP-PRD (ADVP (RB not) (RB significantly)) (JJ different) (PRN (-LRB- -LRB-) (NP-COOD (NP (NP (NN Ro)) (: :) (NP (QP (CD 7687) (CC (- +)) (CD 1750) (CC vs) (CD 7347) (CC (- +)) (CD 1285)) (NN (cell sites)))) (: ;) (NP (NP (NN Kd)) (: :) (NP (NP (QP (CD 7.7) (CC (- +)) (CD 2.4) (CC vs) (CD 7.4) (CC (- +)) (CD 1.7)) (NN nM)) (PP (IN at) (NP (CD 24) (NNS degrees) (NN C)))))) (-RRB- -RRB-)))) (. .)))
(S (S (PP-TMP (IN After) (NP (NP (NN weight) (NN gain)) (PRN (-LRB- -LRB-) (NP (QP (CD 14) (CC (- +)) (CD 2) (TO to) (CD 16) (CC (- +)) (CD 2)) (NN (m2 kg))) (-RRB- -RRB-)))) (, ,) (NP-SBJ (NN receptor) (NNS numbers)) (VP (VBD were) (NP-PRD (NP (NP-COOD (NP (QP (CD 8421) (CC (- +)) (CD 2126)) (NP (-NONE- *RNR*-36)) (PRN (-LRB- -LRB-) (FRAG (JJ pre)) (-RRB- -RRB-))) (CC and) (NP (QP (CD 9011) (CC (- +)) (CD 500)) (NP (-NONE- *RNR*-36)) (PRN (-LRB- -LRB-) (FRAG (JJ post)) (-RRB- -RRB-)))) (NP-36 (NN (cell sites)))) (, ,) (SBAR (WHNP-37 (WDT which)) (S (NP-SBJ (-NONE- *T*-37)) (VP (VBP are) (RB not) (ADJP-PRD (RB significantly) (JJ different) (PRN (-LRB- -LRB-) (S (NP-SBJ (NN P)) (ADJP-PRD (ADJP (JJR greater)) (PP (IN than) (NP (CD 0.2))))) (-RRB- -RRB-)))))))) (: ;)) (S (NP-SBJ (DT the) (NN Kd)) (VP (VBD was) (ADJP-PRD (ADJP (JJ unchanged)) (PRN (-LRB- -LRB-) (NP (QP (CD 9.3) (CC (- +)) (CD 2.6) (CC vs) (CD 9.2) (CC (- +)) (CD 2.4)) (NN nM)) (-RRB- -RRB-)))) (. .)))
(NP (NP (NNS CONCLUSIONS)) (S-COOD (S (NP-SBJ (NN Hypercortisolaemia)) (VP (VBZ does) (RB not) (VP (VB down-regulate) (NP (NP (DT the) (NN lymphocyte) (NN glucocorticoid) (NNS receptors)) (PP (IN in) (NP (NN anorexia) (NN nervosa))))))) (CC and) (S (NP-SBJ-105 (DT a) (JJ post-receptor) (NN defect)) (VP (MD might) (VP (VB be) (VP (VBN involved) (NP (-NONE- *-105)) (PP (IN in) (NP (NP (JJ peripheral) (NN tissue) (NN resistance)) (PP (TO to) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN glucocorticoid) (NNS hormones)) (PP (IN in) (NP (NN undernutrition))))))))))))) (. .)))
